Jean‐Michel Petit

European Association for the Study of the Liver (<scp>EASL</scp>), European Association for the Study of Diabetes (<scp>EASD</scp>) and European Association for the Study of Obesity (<scp>EASO</scp>) clinical practice recommendations for the management of non‐alcoholic fatty liver disease: evaluation of their application in people with Type 2 diabetes

Anne-Laure Sberna, Benjamin Bouillet, Alexia Rouland et al. · Diabetic Medicine · 2017 · 311 citations

Risk factors for diabetes mellitus and early insulin resistance in chronic hepatitis C

Jean‐Michel Petit, Jean‐Baptiste Bour, Catherine Galland-Jos et al. · Journal of Hepatology · 2001 · 277 citations

Metabolic Syndrome, Hepatology, Hepatitis C +10

Sucrose octasulfate dressing versus control dressing in patients with neuroischaemic diabetic foot ulcers (Explorer): an international, multicentre, double-blind, randomised, controlled trial

Michael Edmonds, José Luis Lázaro‐Martínez, J.M. Alfayate-García et al. · The Lancet Diabetes & Endocrinology · 2017 · 252 citations

Versus Control, Diabetes Management, Sucrose Octasulfate +8

Effect of liraglutide therapy on liver fat content in patients with inadequately controlled type 2 diabetes. The Lira-NAFLD study

Jean‐Michel Petit, Jean–Pierre Cercueil, Romaric Loffroy et al. · The Journal of Clinical Endocrinology & Metabolism · 2016 · 224 citations · Full text

PIK3R1 Mutations Cause Syndromic Insulin Resistance with Lipoatrophy

Christel Thauvin‐Robinet, Martine Auclair, Laurence Duplomb et al. · The American Journal of Human Genetics · 2013 · 199 citations · Full text

Metabolic Syndrome, Genetics, Diabetes +3